Association of various risk factors with prognosis and hospitalization cost in Chinese patients with acute myocardial infarction: A clinical analysis of 627 cases
- PMID: 25574242
- PMCID: PMC4280932
- DOI: 10.3892/etm.2014.2087
Association of various risk factors with prognosis and hospitalization cost in Chinese patients with acute myocardial infarction: A clinical analysis of 627 cases
Abstract
Acute myocardial infarction (AMI) is the leading cause of morbidity and mortality in the developed world and is becoming increasingly more common in developing countries. The risk factors affecting the prognosis of Chinese patients may differ from those in other populations. This study was conducted to investigate the potential risk factors that may correlate with prognosis and hospitalization costs of Chinese AMI patients. A total of 627 hospitalized AMI patients were recruited and their general information and relevant laboratory parameters were collected. Accordingly, the patients were grouped into different subgroups and potential risk factors and their correlations with prognosis and hospitalization costs were analyzed. Age, high blood pressure, infarct location and percutaneous coronary intervention (PCI) were the variables significantly associated with the differences in the prognosis of AMI patients (P<0.05), whereas times and duration of hospitalization, high blood pressure, infarct location and PCI treatment were found to be significantly associated with the cost of hospitalization (P<0.05). However, the AMI patients enrolled in this study may not be representative of all AMI patients in China. In addition, the prognosis of these patients was limited to their hospital stay. Therefore, long-term follow-up requires careful assessment.
Keywords: Chinese population; acute myocardial infarction; hospitalization cost; prognosis; risk factors.
Figures



Similar articles
-
Coronary angiography in the elderly with acute myocardial infarction.Int J Cardiol. 2007 Mar 20;116(2):249-56. doi: 10.1016/j.ijcard.2006.03.054. Epub 2006 Jul 12. Int J Cardiol. 2007. PMID: 16839633
-
[Related factors and the long-term outcome after percutaneous coronary intervention of premature acute myocardial infarction].Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Aug 24;48(8):655-660. doi: 10.3760/cma.j.cn112148-20191208-00738. Zhonghua Xin Xue Guan Bing Za Zhi. 2020. PMID: 32847321 Chinese.
-
The potential impact of primary percutaneous coronary intervention on ventricular septal rupture complicating acute myocardial infarction.Chest. 2004 May;125(5):1622-8. doi: 10.1378/chest.125.5.1622. Chest. 2004. PMID: 15136368
-
Surgery as early revascularization after acute myocardial infarction.Anadolu Kardiyol Derg. 2008 Nov;8 Suppl 2:84-92. Anadolu Kardiyol Derg. 2008. PMID: 19028640 Review.
-
Expert Review on the Prognostic Role of Echocardiography after Acute Myocardial Infarction.J Am Soc Echocardiogr. 2017 May;30(5):431-443.e2. doi: 10.1016/j.echo.2017.01.020. J Am Soc Echocardiogr. 2017. PMID: 28477781 Review.
Cited by
-
Penehyclidine Hydrochloride Preconditioning Provides Cardioprotection in a Rat Model of Myocardial Ischemia/Reperfusion Injury.PLoS One. 2015 Dec 2;10(12):e0138051. doi: 10.1371/journal.pone.0138051. eCollection 2015. PLoS One. 2015. PMID: 26632817 Free PMC article.
-
Cost-Effectiveness of Alirocumab for the Secondary Prevention of Cardiovascular Events after Myocardial Infarction in the Chinese Setting.Front Pharmacol. 2021 Apr 14;12:648244. doi: 10.3389/fphar.2021.648244. eCollection 2021. Front Pharmacol. 2021. PMID: 33935749 Free PMC article.
-
The low expression of miR-155 promotes the expression of SHP2 by inhibiting the activation of the ERK1/2 pathway and improves cell pyroptosis induced by I/R in mice.Aging (Albany NY). 2024 Mar 6;16(5):4778-4788. doi: 10.18632/aging.205631. Epub 2024 Mar 6. Aging (Albany NY). 2024. PMID: 38451182 Free PMC article.
-
Cost-effectiveness of universal genetic screening for familial hypercholesterolemia in young adults aged 18-40 years in China.BMC Med. 2025 Mar 5;23(1):139. doi: 10.1186/s12916-025-03966-7. BMC Med. 2025. PMID: 40045404 Free PMC article.
-
Cost-effectiveness of adding ezetimibe and/or PCSK9 inhibitors to high-dose statins for secondary prevention of cardiovascular disease in Chinese adults.Int J Technol Assess Health Care. 2023 Aug 31;39(1):e53. doi: 10.1017/S0266462323000296. Int J Technol Assess Health Care. 2023. PMID: 37650314 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous